Global Autoimmune Partnering 20102017 Deal trends players and financials...
Global Autoimmune Partnering 2010 to 2017 provides the full collection of Autoimmune disease deals signed between the world's pharmaceutical and biotechnology companies since 2010. Trends in Autoimmune...
View ArticleCrohns disease is linked to arthritis by E coli bacteria new findings
A type of E. coli bacteria found in people with Crohn&8217;s disease can trigger inflammation associated with spondyloarthritis according to research in Science Translational Medicine....
View ArticleKenneth Pettine M.D. Releases an Easy to Understand History of the...
In an effort to spread awareness and knowledge of the mesenchymal stem cell Dr. Kenneth Pettine has released an easy to understand history.PRWEB February 15 2017 Kenneth Pettine M.D. is passionate...
View ArticleFDA approves new psoriasis drug
SILVER SPRING Md. Feb. 15 2017 PRNewswireUSNewswire The U.S. Food and Drug Administration today approved Siliq brodalumab to treat adults with moderatetosevere plaque psoriasis. Siliq is administered...
View ArticleValeant Receives FDA Approval Of SILIQ Brodalumab For ModerateToSevere Plaque...
LAVAL Quebec Feb. 16 2017 PRNewswire Valeant Pharmaceuticals International Inc. NYSE & TSX VRX today announced that the U.S. Food and Drug Administration FDA has approved the Biologics License...
View ArticleZitter Health Insights Specialty Pharmacy Patient Satisfaction Survey
An indepth look at the survey history and methodologyPRWEB February 16 2017 Zitter Health Insights ZHI has been providing life science specialty pharmacy and managed care organizations insights that...
View ArticleTakeda And TiGenix Report New Data Highlighting Maintenance Of LongTerm...
Life Sciences Jobs ...
View ArticleJanssen Biotech Release New Data Shows STELARA ustekinumab Maintained...
Life Sciences Jobs ...
View ArticleCelltrion Healthcare Releases Positive Results From Pivotal Study In Crohns...
Life Sciences Jobs ...
View ArticlePfizer Release New Data In Crohns Disease Patients Shows Similar Efficacy And...
Life Sciences Jobs ...
View ArticleTakeda and TiGenix Report New Data Highlighting Maintenance of LongTerm...
PRESS RELEASE Takeda and TiGenix Report New Data Highlighting Maintenance of LongTerm Remission of Complex Perianal Fistulas in Crohn's Disease Patients with Cx601 52week results of the Phase 3...
View ArticleIQ4I Research & Consultancy Published a New Report on Incontinence and Ostomy...
Boston MA February 17 2017 PR.com Incontinence is the involuntary loss of urine or stool this is a widespread condition and varies with severity from small leaks to complete loss of control of the...
View ArticleProtagonist Therapeutics Presents Data on Oral Peptide Drug Candidates at...
MILPITAS Calif. Feb. 17 2017 PRNewswire Protagonist Therapeutics Inc. NASDAQ PTGX today presented two posters detailing data on its oral peptide drug candidates PTG100 and PTG200 at the 12th Congress...
View ArticleTiGenix Takeda and TiGenix Report New Data Highlighting Maintenance of...
PRESS RELEASE Takeda and TiGenix Report New Data Highlighting Maintenance of LongTerm Remission of Complex Perianal Fistulas in Crohn's Disease Patients with Cx601 52week results of the Phase 3 ...
View ArticleNew Data Shows STELARAÂ ustekinumab Maintained Clinical Response And...
HORSHAM Pa. Feb. 17 2017 PRNewswire Janssen Biotech Inc. announced today new twoyear data from the ongoing IMUNITI longterm extension LTE study evaluating the efficacy and safety of subcutaneous SC...
View ArticleTheravance Biopharma Presents Positive Clinical Data on TD1473 at the 12th...
DUBLIN Feb. 17 2017 PRNewswire Theravance Biopharma Inc. NASDAQ TBPH "Theravance Biopharma" or the "Company" today announced the presentation of positive clinical data for TD1473 a novel potent and...
View ArticleImmune Pharmaceuticals Announces the launch of REMAIN an international...
NEW YORK Feb. 17 2017 PRNewswire Immune Pharmaceuticals Inc. Nasdaq IMNP will announce on Monday February 20th 2017 at the Acute Leukemia XVI symposium in Munich Germany that it will be launching...
View ArticleTakeda and TiGenix announce successful trial of Crohns disease drug
Takeda and TiGenix announced Phase 3 results from a trial looking into the investigational compound Cx601 a treatment for refractory complex perianal fistulas in sufferers of Crohns disease. The...
View ArticleProtagonist Therapeutics Presents Data on Oral Peptide Drug Candidates at...
Poster Presentation Details Poster Number P113ÂModelbased predictions of the PTG100 pharmacodynamic PD responses in Ulcerative Colitis patients. Date and time Fr...
View ArticleTiGenix cell therapy for Crohn's fistulas shows longterm benefit
Phase III datafor the Takedapartnered drug raises hopes for upcoming EU approval
View Article